Allergan Acquires Vitae Pharmaceuticals to Strengthen Its Dermatology Portfolio
By Keshav Mahawar
Pharma Deals Review: Vol 2016 Issue 9 (Table of Contents)
Published: 24 Sep-2016
DOI: 10.3833/pdr.v2016.i9.2194 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
After agreeing to sell its generics business to Teva earlier this year for US$40...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS